Delic Holdings announces receiving a Health Canada 56 Research Exemption to conduct research on various psychedelic drugs.
Articles
Mydecine Announces Reverse Stock-Split
Mydecine Innovations Group announces a share consolidation of 1 post-consolidation share for every 50 pre-consolidation shares.
Red Light Holland Sponsors First Of Its Kind Group Microdosing Concert In The Netherlands
Red Light Holland to sponsor a "microdosing concert" in The Netherlands, given by mezza-soprano Helena van Heel.
Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT
In many studies, DMT has shown to be a promising and effective psychedelic for the treatment of mental health issues.
Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway
Awakn Life Sciences reports that it now has three clinics in operation, including its new flagship clinic in London.
Magic mushrooms can lead to long-term improvements in depression, study finds
Magic mushroom's drug psilocybin can lead to long-term improvements in depression symptom severity, a small study has found.
Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research
Numinus Wellness is acquiring Novamind Inc in an all-share deal valued at CAD$26.2 million, creating an industry leader in research AND treatment.
Red Light Holland to Purchase 100 Acres of Farmland in Ontario, Canada as Its Mushroom Farms Division Expands in North America
Red Light Holland announces the purchase of 100 acres of farmland in Ontario that it is targeting for mushroom cultivation.
How Minera Alamos Turns $20 Of Exploration Spending Into $2,000 Of Gold
From exploration right through to production, Minera Alamos epitomizes efficiency in gold mining.
Red Light Holland Appoints New Chief Marketing Officer
Red Light Holland's new Chief Marketing Officer, Ridley Doolittle, has extensive experience in brand development, including a senior position with Bacardi.
Revitalist Announces Private Placement Offering of up To CDN$6 Million
Revitalist announces a CAD$6 million private placement of convertible notes and warrants. Notes can be converted into common shares at a price of CAD$0.15.
Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery of Multiple Psychedelic Molecules
Cybin announces the publication bu WIPO of Cybin's patent application for psychedelics-based delivery systems.
Red Light Holland CTIO, Sarah Hashkes, Publishes Microdosing Article and will be Participating in an Online Webinar by Harvard's Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center at Harvard Law School
Red Light Holland announces it is participating in a Harvard-sponsored online webinar on psychedelic drug law policy.
Awakn Successfully Completes Phase One of Its Drug Discovery Program
Awakn Life Sciences announces the completion of its "hit to lead" program on developing new chemical entities (NCE).
Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104
Field Trip announces receiving broad patent protection for its novel molecule, FT-104, from the USPTO.